Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Optimization of gold nanoparticle-based real-time colorimetric assay of dipeptidyl peptidase IV activity.

Aldewachi HS, Woodroofe N, Turega S, Gardiner PHE.

Talanta. 2017 Jul 1;169:13-19. doi: 10.1016/j.talanta.2017.03.039. Epub 2017 Mar 18.

PMID:
28411801
2.

Alcohol-related cerebellar degeneration: not all down to toxicity?

Shanmugarajah PD, Hoggard N, Currie S, Aeschlimann DP, Aeschlimann PC, Gleeson DC, Karajeh M, Woodroofe N, Grünewald RA, Hadjivassiliou M.

Cerebellum Ataxias. 2016 Oct 3;3:17. eCollection 2016.

3.

Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis.

Carter A, Humphreys L, Snowdon N, Sharrack B, Daley A, Petty J, Woodroofe N, Saxton J.

Trials. 2015 Oct 15;16:468. doi: 10.1186/s13063-015-0996-3.

4.

Identified HLA class I epitopes can undergo conformational induced variation due to changes within HLA bound peptides.

Battle R, Turner D, Woodroofe N, Clark B.

Immunol Lett. 2014 Sep;161(1):57-8. doi: 10.1016/j.imlet.2014.04.016. Epub 2014 May 6. No abstract available.

PMID:
24814692
5.

Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.

Carter A, Daley A, Humphreys L, Snowdon N, Woodroofe N, Petty J, Roalfe A, Tosh J, Sharrack B, Saxton JM.

Mult Scler. 2014 Jul;20(8):1112-22. doi: 10.1177/1352458513519354. Epub 2014 Jan 13.

PMID:
24421303
6.

The relationship of HLA-class I derived leader peptide mismatch and renal function within the first 12 months post-renal transplant.

Battle R, Woodroofe N, Clench M, Clark B.

Tissue Antigens. 2013 Oct;82(4):291-2. doi: 10.1111/tan.12191. Epub 2013 Aug 27. No abstract available.

PMID:
24033130
7.

Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: a randomised controlled feasibility study.

Carter AM, Daley AJ, Kesterton SW, Woodroofe NM, Saxton JM, Sharrack B.

Contemp Clin Trials. 2013 Jul;35(2):40-7. doi: 10.1016/j.cct.2013.04.003. Epub 2013 Apr 21.

PMID:
23612222
8.

Transglutaminase 6 antibodies in the diagnosis of gluten ataxia.

Hadjivassiliou M, Aeschlimann P, Sanders DS, Mäki M, Kaukinen K, Grünewald RA, Bandmann O, Woodroofe N, Haddock G, Aeschlimann DP.

Neurology. 2013 May 7;80(19):1740-5. doi: 10.1212/WNL.0b013e3182919070. Epub 2013 Apr 10.

PMID:
23576621
9.

Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study.

Stout M, Tew GA, Doll H, Zwierska I, Woodroofe N, Channer KS, Saxton JM.

Am Heart J. 2012 Dec;164(6):893-901. doi: 10.1016/j.ahj.2012.09.016. Epub 2012 Oct 30.

PMID:
23194490
10.

Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: a randomized controlled trial.

Scott E, Daley AJ, Doll H, Woodroofe N, Coleman RE, Mutrie N, Crank H, Powers HJ, Saxton JM.

Cancer Causes Control. 2013 Jan;24(1):181-91. doi: 10.1007/s10552-012-0104-x. Epub 2012 Nov 27.

PMID:
23184120
11.

GAD antibody-associated neurological illness and its relationship to gluten sensitivity.

Hadjivassiliou M, Aeschlimann D, Grünewald RA, Sanders DS, Sharrack B, Woodroofe N.

Acta Neurol Scand. 2011 Mar;123(3):175-80. doi: 10.1111/j.1600-0404.2010.01356.x.

PMID:
20456245
12.

Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension.

Dhungana S, Waters P, Ismail A, Woodroofe N, Vincent A, Sharrack B.

J Neurol. 2010 Jul;257(7):1211-2. doi: 10.1007/s00415-010-5499-2. Epub 2010 Mar 16. No abstract available.

PMID:
20232212
13.

Gluten sensitivity: from gut to brain.

Hadjivassiliou M, Sanders DS, Grünewald RA, Woodroofe N, Boscolo S, Aeschlimann D.

Lancet Neurol. 2010 Mar;9(3):318-30. doi: 10.1016/S1474-4422(09)70290-X. Review.

PMID:
20170845
14.

Idiopathic intracranial hypertension.

Dhungana S, Sharrack B, Woodroofe N.

Acta Neurol Scand. 2010 Feb;121(2):71-82. doi: 10.1111/j.1600-0404.2009.01172.x. Epub 2009 Nov 23. Review.

PMID:
19930211
15.

IL-1β, TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls.

Dhungana S, Sharrack B, Woodroofe N.

Clin Endocrinol (Oxf). 2009 Dec;71(6):896-7. doi: 10.1111/j.1365-2265.2009.03593.x. Epub 2009 Mar 28. No abstract available.

PMID:
19508602
16.

Cytokines and chemokines in idiopathic intracranial hypertension.

Dhungana S, Sharrack B, Woodroofe N.

Headache. 2009 Feb;49(2):282-5. doi: 10.1111/j.1526-4610.2008.001329.x.

PMID:
19222599
17.

Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase.

Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D.

Ann Neurol. 2008 Sep;64(3):332-43. doi: 10.1002/ana.21450.

PMID:
18825674
18.

Gluten ataxia.

Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Grünewald RA.

Cerebellum. 2008;7(3):494-8. doi: 10.1007/s12311-008-0052-x. Review.

PMID:
18787912
19.

Cerebellar ataxia as a possible organ-specific autoimmune disease.

Hadjivassiliou M, Boscolo S, Tongiorgi E, Grünewald RA, Sharrack B, Sanders DS, Woodroofe N, Davies-Jones GA.

Mov Disord. 2008 Jul 30;23(10):1370-7. doi: 10.1002/mds.22129.

PMID:
18546342
20.

Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia.

Hadjivassiliou M, Mäki M, Sanders DS, Williamson CA, Grünewald RA, Woodroofe NM, Korponay-Szabó IR.

Neurology. 2006 Feb 14;66(3):373-7.

PMID:
16476935

Supplemental Content

Loading ...
Support Center